1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. Middle East & Africa Fish Vaccines Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. Middle East & Africa Fish Vaccines Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. Middle East & Africa Fish Vaccines Market Regional Analysis
6.2 Middle East & Africa Fish Vaccines Market Revenue 2020-2030 (US$ Million)
6.3 Middle East & Africa Fish Vaccines Market Forecast Analysis
7. Middle East & Africa Fish Vaccines Market Analysis – by Vaccine Type
7.1 Inactivated Vaccines
- 7.1.1 Overview
- 7.1.2 Inactivated Vaccines: Middle East & Africa Fish Vaccines Market – Revenue and Forecast, 2020-2030 (US$ Million)
7.2 Live Attenuated Vaccines
- 7.2.1 Overview
- 7.2.2 Live Attenuated Vaccines: Middle East & Africa Fish Vaccines Market – Revenue and Forecast, 2020-2030 (US$ Million)
7.3 Subunit Vaccines
- 7.3.1 Overview
- 7.3.2 Subunit Vaccines: Middle East & Africa Fish Vaccines Market – Revenue and Forecast, 2020-2030 (US$ Million)
7.4 Recombinant Vector Vaccine
- 7.4.1 Overview
- 7.4.2 Recombinant Vector Vaccine: Middle East & Africa Fish Vaccines Market – Revenue and Forecast, 2020-2030 (US$ Million)
8. Middle East & Africa Fish Vaccines Market Analysis – by Application
8.1 Bacterial Infection
- 8.1.1 Overview
- 8.1.2 Bacterial Infection: Middle East & Africa Fish Vaccines Market – Revenue and Forecast, 2020-2030 (US$ Million)
8.2 Viral Infection
- 8.2.1 Overview
- 8.2.2 Viral Infection: Middle East & Africa Fish Vaccines Market – Revenue and Forecast, 2020-2030 (US$ Million)
8.3 Parasitic
- 8.3.1 Overview
- 8.3.2 Parasitic: Middle East & Africa Fish Vaccines Market – Revenue and Forecast, 2020-2030 (US$ Million)
9. Middle East & Africa Fish Vaccines Market Analysis – by Route of Administration
9.1 Injection Vaccine
- 9.1.1 Overview
- 9.1.2 Injection Vaccine: Middle East & Africa Fish Vaccines Market – Revenue and Forecast, 2020-2030 (US$ Million)
9.2 Immersion Vaccine
- 9.2.1 Overview
- 9.2.2 Immersion Vaccine: Middle East & Africa Fish Vaccines Market – Revenue and Forecast, 2020-2030 (US$ Million)
9.3 Oral Vaccine
- 9.3.1 Overview
- 9.3.2 Oral Vaccine: Middle East & Africa Fish Vaccines Market – Revenue and Forecast, 2020-2030 (US$ Million)
10. Middle East & Africa Fish Vaccines Market Analysis – by Species
10.1 Salmon
- 10.1.1 Overview
- 10.1.2 Salmon: Middle East & Africa Fish Vaccines Market – Revenue and Forecast, 2020-2030 (US$ Million)
10.2 Trout
- 10.2.1 Overview
- 10.2.2 Trout: Middle East & Africa Fish Vaccines Market – Revenue and Forecast, 2020-2030 (US$ Million)
10.3 Tilapia
- 10.3.1 Overview
- 10.3.2 Tilapia: Middle East & Africa Fish Vaccines Market – Revenue and Forecast, 2020-2030 (US$ Million)
11. Middle East & Africa Fish Vaccines Market – Middle East and Africa Analysis
11.1 Overview
11.2 Middle East and Africa
- 11.2.1 Middle East & Africa Fish Vaccines Market Breakdown, by Key
Country, 2023 and 2030 (%)
- 11.2.1.1 Middle East & Africa Fish Vaccines Market – Revenue and
Forecast Analysis – by Country
- 11.2.1.1 South Africa:
Middle East & Africa Fish Vaccines Market – Revenue and Forecast to 2030 (US$ Million)
- 11.2.1.1.1 South Africa: Middle East & Africa Fish Vaccines Market Breakdown, by Vaccine Type
- 11.2.1.1.2 South Africa: Middle East & Africa Fish Vaccines Market Breakdown, by Application
- 11.2.1.1.3 South Africa: Middle East & Africa Fish Vaccines Market Breakdown, by Route of Administration
- 11.2.1.1.4 South Africa: Middle East & Africa Fish Vaccines Market Breakdown, by Species
- 11.2.1.2 Saudi Arabia:
Middle East & Africa Fish Vaccines Market – Revenue and Forecast to 2030 (US$ Million)
- 11.2.1.2.1 Saudi Arabia: Middle East & Africa Fish Vaccines Market Breakdown, by Vaccine Type
- 11.2.1.2.2 Saudi Arabia: Middle East & Africa Fish Vaccines Market Breakdown, by Application
- 11.2.1.2.3 Saudi Arabia: Middle East & Africa Fish Vaccines Market Breakdown, by Route of Administration
- 11.2.1.2.4 Saudi Arabia: Middle East & Africa Fish Vaccines Market Breakdown, by Species
- 11.2.1.3 UAE:
Middle East & Africa Fish Vaccines Market – Revenue and Forecast to 2030 (US$ Million)
- 11.2.1.3.1 UAE: Middle East & Africa Fish Vaccines Market Breakdown, by Vaccine Type
- 11.2.1.3.2 UAE: Middle East & Africa Fish Vaccines Market Breakdown, by Application
- 11.2.1.3.3 UAE: Middle East & Africa Fish Vaccines Market Breakdown, by Route of Administration
- 11.2.1.3.4 UAE: Middle East & Africa Fish Vaccines Market Breakdown, by Species
- 11.2.1.4 Rest of Middle East and Africa:
Middle East & Africa Fish Vaccines Market – Revenue and Forecast to 2030 (US$ Million)
- 11.2.1.4.1 Rest of Middle East and Africa: Middle East & Africa Fish Vaccines Market Breakdown, by Vaccine Type
- 11.2.1.4.2 Rest of Middle East and Africa: Middle East & Africa Fish Vaccines Market Breakdown, by Application
- 11.2.1.4.3 Rest of Middle East and Africa: Middle East & Africa Fish Vaccines Market Breakdown, by Route of Administration
- 11.2.1.4.4 Rest of Middle East and Africa: Middle East & Africa Fish Vaccines Market Breakdown, by Species
12. Competitive Landscape
12.1 Heat Map Analysis
12.2 Company Positioning and Concentration
13. Industry Landscape
13.1 Overview
13.2 Market Initiative
13.3 Partnerships and Collaborations
13.4 Other Developments
14. Company Profiles
14.1 Elanco Animal Health Inc
- 14.1.1 Key Facts
- 14.1.2 Business Description
- 14.1.3 Products and Services
- 14.1.4 Financial Overview
- 14.1.5 SWOT Analysis
- 14.1.6 Key Developments
14.2 Hipra SA
- 14.2.1 Key Facts
- 14.2.2 Business Description
- 14.2.3 Products and Services
- 14.2.4 Financial Overview
- 14.2.5 SWOT Analysis
- 14.2.6 Key Developments
14.3 Merck & Co Inc.
- 14.3.1 Key Facts
- 14.3.2 Business Description
- 14.3.3 Products and Services
- 14.3.4 Financial Overview
- 14.3.5 SWOT Analysis
- 14.3.6 Key Developments
14.4 Phibro Animal Health Corp
- 14.4.1 Key Facts
- 14.4.2 Business Description
- 14.4.3 Products and Services
- 14.4.4 Financial Overview
- 14.4.5 SWOT Analysis
- 14.4.6 Key Developments
14.5 Vaxxinova International BV
- 14.5.1 Key Facts
- 14.5.2 Business Description
- 14.5.3 Products and Services
- 14.5.4 Financial Overview
- 14.5.5 SWOT Analysis
- 14.5.6 Key Developments
14.6 Zoetis Inc.
- 14.6.1 Key Facts
- 14.6.2 Business Description
- 14.6.3 Products and Services
- 14.6.4 Financial Overview
- 14.6.5 SWOT Analysis
- 14.6.6 Key Developments
15. Appendix
15.1 About Business Market Insights
15.2 List of Abbreviations